web analytics
23.7 C
Munich
Wednesday, June 29, 2022

Bulls Take Charge of Rising Biosciences Inc (OTCMKTS: RBII)

Rising Biosciences Inc (OTCMKTS: RBII) is making an explosive move up the charts surging higher in massive volume as legions of new shareholders jump on board and continue to bid up shares of RBII.

The move comes after the Company announced significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. Oxi Thyme has introduced a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost effectively.

Rising Biosciences Inc (OTCMKTS: RBII) operates three distinct business units. The first business unit is a physicians practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

Earlier this year the Company reported the production launch of Oxithymol™ a proprietary, non-toxic, blended formula of CDC approved hydrogen peroxide, thymol and other natural, environmentally safe ingredients. Oxithymol™ disinfectant solution is applied via the Oxi Thyme™ atomizing ULV/HPLV fogging system. The “no touch” system is effective in killing disease-causing microbial pathogens on hard surfaces, and is suitable for residential, commercial and automotive settings. RBII joined a number of other regional manufacturers, in responding to Governor DeWine’s appeal.

To Find out the inside Scoop on RBII  subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RBIIOn July 17 RBII announced significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. Oxi Thyme has introduced a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost effectively. Utilizing a proprietary formulated EPA registered Hydrogen Peroxide disinfectant, developed with a surfactant, or surface active agent, Oxi Thyme improves efficiency by lowering surface tension. The addition of a surfactant and the use of an atomizing ULV (ultra low volume) or HVLP (high volume, low pressure) fogging system allows the droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitizing large areas quickly and efficiently leaving no toxic residue.

Arthur Hall CEO of RBII commented:  “The activity over the last three months has been incredible. We have already outgrown our original bottling plant and are in the process of building a second bottling facility in South Florida. Currently, we are operating in 14 states, servicing 74 regions from Anchorage, AK to Key West, FL, with more going on line each week. We are living in challenging times”, Hall added, “and experiencing a dramatic climate of change with this Covid-19 pandemic. People are struggling to establish what our new normal will be with respect to safety standards. Oxi Thyme has heard the call and we are here to help!”

We have a Big Pick Coming. Subscribe Right Now!

Currently running up the charts RBII is an exciting story developing in small caps; Oxi Thyme has introduced a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost effectively. Utilizing a proprietary formulated EPA registered Hydrogen Peroxide disinfectant, developed with a surfactant, or surface active agent, Oxi Thyme improves efficiency by lowering surface tension. The addition of a surfactant and the use of an atomizing ULV (ultra low volume) or HVLP (high volume, low pressure) fogging system allows the droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitizing large areas quickly and efficiently leaving no toxic residue. The Company just reported significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. There seems to be little or no dilution. We will be updating on RBII when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RBII.

WAIT! Do You Want Stocks That Could Go Up 348% In Days Delivered To Your Inbox For FREE?

Disclosure: we hold no position in RBII either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.